Suppr超能文献

炎性关节炎患者血清和滑液中白细胞介素-10家族细胞因子的分布揭示了其对全身炎症和关节炎症的不同作用。

Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation.

作者信息

Scrivo R, Conigliaro P, Riccieri V, Di Franco M, Alessandri C, Spadaro A, Perricone R, Valesini G

机构信息

Dipartimento di Medicina Interna e Specialità Mediche, Reumatologia, Sapienza Università di Roma, Roma, Italy.

出版信息

Clin Exp Immunol. 2015 Feb;179(2):300-8. doi: 10.1111/cei.12449.

Abstract

Evidence exists that interleukin (IL)-10 family cytokines may be involved in the pathogenesis of rheumatoid arthritis (RA). We sought to determine whether or not these cytokines are involved in psoriatic arthritis (PsA). We conducted a prospective study on patients with PsA, RA and osteoarthritis (OA); healthy controls (HC) were also included. We analysed IL-20, IL-24 and IL-19 serum and synovial fluid (SF) levels and change of serum levels following treatment with biological agents. IL-20 serum levels were increased in PsA and RA compared with OA patients and HC and with matched SF levels. IL-24 serum levels in PsA, RA and OA patients were higher than those in HC and also with respect to matched SF in PsA. IL-19 serum levels were higher in HC and OA compared with PsA and RA patients; IL-19 SF levels were higher in PsA and RA compared with OA patients, and in PsA compared with RA patients. PsA and RA patients showed a reduction of IL-19 serum levels after biological treatment. Therefore, IL-19 seems to be involved mainly in the joint inflammation, whereas IL-20 and IL-24 appear to participate mainly in the systemic responses. These findings may further the comprehension of the contribution of these cytokines to the inflammatory response involved in chronic arthritis, as well as to the development of novel therapeutic strategies.

摘要

有证据表明白细胞介素(IL)-10家族细胞因子可能参与类风湿关节炎(RA)的发病机制。我们试图确定这些细胞因子是否参与银屑病关节炎(PsA)。我们对PsA、RA和骨关节炎(OA)患者进行了一项前瞻性研究;也纳入了健康对照(HC)。我们分析了IL-20、IL-24和IL-19的血清和滑液(SF)水平以及生物制剂治疗后血清水平的变化。与OA患者和HC相比,PsA和RA患者的IL-20血清水平升高,且与匹配的SF水平相关。PsA、RA和OA患者的IL-24血清水平高于HC,且与PsA中匹配的SF水平相关。与PsA和RA患者相比,HC和OA患者的IL-19血清水平更高;与OA患者相比,PsA和RA患者的IL-19 SF水平更高,且与RA患者相比,PsA患者的IL-19 SF水平更高。生物治疗后,PsA和RA患者的IL-19血清水平降低。因此,IL-19似乎主要参与关节炎症,而IL-20和IL-24似乎主要参与全身反应。这些发现可能会进一步加深对这些细胞因子在慢性关节炎炎症反应中的作用的理解,以及对新型治疗策略的开发。

相似文献

2
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.
Joint Bone Spine. 2012 Jan;79(1):32-7. doi: 10.1016/j.jbspin.2011.02.011. Epub 2011 Mar 26.
3
Interleukin 13 in synovial fluid and serum of patients with psoriatic arthritis.
Ann Rheum Dis. 2002 Feb;61(2):174-6. doi: 10.1136/ard.61.2.174.
10
Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.
Rheumatology (Oxford). 2020 Apr 1;59(4):828-838. doi: 10.1093/rheumatology/kez358.

引用本文的文献

6
Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus.
Clin Rheumatol. 2021 Jul;40(7):2707-2715. doi: 10.1007/s10067-021-05618-6. Epub 2021 Feb 3.
8
The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis.
Front Immunol. 2018 Sep 25;9:2226. doi: 10.3389/fimmu.2018.02226. eCollection 2018.
9
Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers.
Proteomes. 2018 Jan 24;6(1):5. doi: 10.3390/proteomes6010005.
10
Autocrine Interleukin-10 Mediates Glucagon-Like Peptide-1 Receptor-Induced Spinal Microglial β-Endorphin Expression.
J Neurosci. 2017 Nov 29;37(48):11701-11714. doi: 10.1523/JNEUROSCI.1799-17.2017. Epub 2017 Oct 30.

本文引用的文献

1
Fibroblasts and synovial immunity.
Curr Opin Pharmacol. 2013 Aug;13(4):565-9. doi: 10.1016/j.coph.2013.04.001. Epub 2013 Apr 20.
2
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii2-34. doi: 10.1136/annrheumdis-2013-203348.
4
The pathogenesis of rheumatoid arthritis.
N Engl J Med. 2011 Dec 8;365(23):2205-19. doi: 10.1056/NEJMra1004965.
5
Interleukin-19 blockade attenuates collagen-induced arthritis in rats.
Rheumatology (Oxford). 2012 Mar;51(3):434-42. doi: 10.1093/rheumatology/ker127. Epub 2011 Jun 29.
7
IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
Expert Opin Ther Targets. 2011 Feb;15(2):119-26. doi: 10.1517/14728222.2011.534461. Epub 2010 Nov 12.
8
Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis.
Arthritis Rheum. 2010 Nov;62(11):3311-21. doi: 10.1002/art.27689.
9
Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints.
Scand J Rheumatol. 2010 Mar;39(2):118-26. doi: 10.3109/03009740903170823.
10
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.
Ann Rheum Dis. 2010 Mar;69(3):483-9. doi: 10.1136/ard.2009.113100. Epub 2009 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验